pharmaglobenews, Author at Pharma Globenewswire

Substance Use Disorder Market Insights, Epidemiology, and Market Forecast 2034

DelveInsight’s “Substance Use Disorder Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of Substance Use Disorder, historical and forecasted epidemiology as well as the Substance Use Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France)

24 April 2026

Uncategorised

IgA Nephropathy Market Set to Surpass USD 1.5 Billion in 2025 Amid Rising Disease Awareness, Novel Therapies, and Expanding Treatment Landscape Across Seven Major Markets

IgA Nephropathy Market Summary IgA Nephropathy (IgAN) Insights and Trends The IgA Nephropathy market has emerged as one of the most dynamic and rapidly evolving segments within the rare kidney disease space. According to DelveInsight’s analysis, the IgA Nephropathy (IgAN) market size

24 April 2026

Clinical Trials·News·Reports

Thyroid Eye Disease Pipeline Accelerates with 20+ Companies Advancing Innovative Therapies Across Clinical Stages

Thyroid Eye Disease (TED), also known as Graves’ ophthalmopathy, is a serious autoimmune inflammatory condition that targets the orbital tissues, including muscles and fat surrounding the eyes. Closely linked to Graves’ disease and other thyroid dysfunctions, TED often emerges in patients with

23 April 2026

Uncategorised

Acute Myocardial Infarction Market Set to Surge from USD 1,630 Million in 2025 to USD 5,392 Million by 2034, Driven by Innovative Therapies and Rising Cardiovascular Disease Burden

Acute Myocardial Infarction Market Summary The Acute Myocardial Infarction market was valued at around USD 1,630 million in 2025 and is projected to reach nearly USD 5,392 million by 2034, growing at a notable CAGR of 14.2% during the study period from

23 April 2026

Market Insights·Reports

General Surgery Devices Market Size to Surpass USD 35.4 Billion by 2032

The global General Surgery Devices Market Size, Trends, and Forecast 2032 is poised for substantial growth, driven by the increasing volume of surgical procedures, rapid adoption of minimally invasive surgical devices, and continuous advancements in robotic-assisted surgery technologies. According to DelveInsight’s latest

22 April 2026

Uncategorised

Immune Thrombocytopenic Purpura Market Poised for Significant Growth Driven by Novel Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2034

Immune Thrombocytopenic Purpura (ITP) Market Key Highlights The Immune Thrombocytopenic Purpura market is entering a transformative phase, shaped by an evolving therapeutic landscape, a robust pipeline of emerging treatments, and a growing understanding of disease mechanisms. The total market size across the

22 April 2026

Clinical Trials·News·Reports

Celiac Disease Pipeline Advances as 25+ Companies Progress 30+ Therapies Across Clinical Trials

Key companies actively involved in the celiac disease drug development landscape include Takeda, Anokion SA, Mozart Therapeutics, AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical Co., Ltd., Calypso Biotech, ImmunogenX Inc., Amgen Inc., and several other emerging biotechnology innovators. According to DelveInsight’s latest

21 April 2026

Uncategorised

Obesity Market Insights, Epidemiology, and Market Forecast 2034

DelveInsight’s “Obesity Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of obesity, historical and forecasted epidemiology as well as the obesity market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.

21 April 2026

Uncategorised

Ewing Sarcoma Market Set to Expand Significantly Amid Rising Pipeline Activity, Novel Therapies, and Growing Unmet Clinical Needs Globally

Ewing Sarcoma Insights and Trends Ewing sarcoma is a malignant small round cell tumor characterized by specific genetic fusions, primarily affecting bones and soft tissues in young individuals. The disease typically originates in the diaphysis and diaphyseal metaphyseal regions of long bones,

21 April 2026

Clinical Trials·News·Reports

Melanoma Clinical Trials 2025: EMA, PDMA, FDA Approvals and Companies

Melanoma Companies are IO Biotech, Moderna Inc., Merck Sharp & Dohme LLC, BioNTech SE, TILT Biotherapeutics LLC, Nykode Therapeutics, Achilles Therapeutics UK Limited, Evaxion Biotech, InxMed, AiVita Biomedical, Cytovation AS, Ono Pharmaceuticals, Neon Therapeutics, Iovance Biotherapeutics, and others. (Albany, USA) DelveInsight’s, “Melanoma Pipeline

20 April 2026

pharmaglobenews

Substance Use Disorder Market Insights, Epidemiology, and Market Forecast 2034

IgA Nephropathy Market Set to Surpass USD 1.5 Billion in 2025 Amid Rising Disease Awareness, Novel Therapies, and Expanding Treatment Landscape Across Seven Major Markets

Thyroid Eye Disease Pipeline Accelerates with 20+ Companies Advancing Innovative Therapies Across Clinical Stages

Acute Myocardial Infarction Market Set to Surge from USD 1,630 Million in 2025 to USD 5,392 Million by 2034, Driven by Innovative Therapies and Rising Cardiovascular Disease Burden

General Surgery Devices Market Size to Surpass USD 35.4 Billion by 2032

Immune Thrombocytopenic Purpura Market Poised for Significant Growth Driven by Novel Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2034

Celiac Disease Pipeline Advances as 25+ Companies Progress 30+ Therapies Across Clinical Trials

Obesity Market Insights, Epidemiology, and Market Forecast 2034

Ewing Sarcoma Market Set to Expand Significantly Amid Rising Pipeline Activity, Novel Therapies, and Growing Unmet Clinical Needs Globally

Melanoma Clinical Trials 2025: EMA, PDMA, FDA Approvals and Companies

Recent Posts

Banner

Newsletter

Authors